Retirement Systems Of Alabama Amgen Inc Transaction History

Retirement Systems Of Alabama

$25.6 Billion
Q2 2024

A detailed history of Retirement Systems Of Alabama transactions in Amgen Inc stock. As of the latest transaction made, Retirement Systems Of Alabama holds 118,331 shares of AMGN stock, worth $37.3 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

118,331

Previous 118,082 0.21%

Holding current value

$37.3 Million

Previous $33.6 Million 10.12%

% of portfolio

0.14%

Previous 0.13%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	BUY	$262.75 - $319.31 $65,424 - $79,508	249 Added 0.21%	118,331 $37 Million
Q1 2024 Apr 30, 2024	BUY	$268.87 - $324.56 $36,028 - $43,491	134 Added 0.11%	118,082 $33.6 Million
Q4 2023 Feb 05, 2024	SELL	$255.7 - $288.46 $766,844 - $865,091	-2,999 Reduced 2.48%	117,948 $34 Million
Q3 2023 Nov 06, 2023	SELL	$218.65 - $271.46 $107,794 - $133,829	-493 Reduced 0.41%	120,947 $32.5 Million
Q2 2023 Jul 31, 2023	SELL	$214.27 - $253.37 $7.8 Million - $9.22 Million	-36,388 Reduced 23.06%	121,440 $27 Million
Q1 2023 May 01, 2023	SELL	$225.79 - $275.2 $2.96 Million - $3.61 Million	-13,110 Reduced 7.67%	157,828 $38.2 Million
Q4 2022 Feb 06, 2023	SELL	$229.03 - $291.01 $1.54 Million - $1.96 Million	-6,738 Reduced 3.79%	170,938 $44.9 Million
Q3 2022 Nov 04, 2022	SELL	$224.46 - $253.15 $6.92 Million - $7.8 Million	-30,814 Reduced 14.78%	177,676 $40 Million
Q2 2022 Aug 03, 2022	SELL	$230.71 - $256.74 $3.48 Million - $3.87 Million	-15,085 Reduced 6.75%	208,490 $50.7 Million
Q1 2022 Apr 20, 2022	SELL	$219.27 - $242.57 $1.19 Million - $1.32 Million	-5,434 Reduced 2.37%	223,575 $54.1 Million
Q4 2021 Jan 20, 2022	SELL	$198.88 - $227.6 $756,738 - $866,018	-3,805 Reduced 1.63%	229,009 $51.5 Million
Q3 2021 Nov 03, 2021	SELL	$212.27 - $248.7 $2.06 Million - $2.41 Million	-9,707 Reduced 4.0%	232,814 $49.5 Million
Q2 2021 Jul 21, 2021	SELL	$233.58 - $259.14 $1.45 Million - $1.61 Million	-6,210 Reduced 2.5%	242,521 $59.1 Million
Q1 2021 Apr 15, 2021	SELL	$221.91 - $258.6 $3.48 Million - $4.05 Million	-15,662 Reduced 5.92%	248,731 $61.9 Million
Q4 2020 Jan 26, 2021	BUY	$216.38 - $257.67 $327,815 - $390,370	1,515 Added 0.58%	264,393 $60.8 Million
Q3 2020 Oct 20, 2020	SELL	$234.65 - $260.95 $2.72 Million - $3.02 Million	-11,589 Reduced 4.22%	262,878 $66.8 Million
Q2 2020 Jul 23, 2020	SELL	$197.81 - $242.74 $3.09 Million - $3.8 Million	-15,638 Reduced 5.39%	274,467 $64.7 Million
Q1 2020 Apr 20, 2020	BUY	$182.24 - $241.7 $56,312 - $74,685	309 Added 0.11%	290,105 $58.8 Million
Q4 2019 Jan 28, 2020	SELL	$189.21 - $243.2 $365,364 - $469,619	-1,931 Reduced 0.66%	289,796 $69.9 Million
Q3 2019 Oct 30, 2019	SELL	$174.11 - $208.62 $4.72 Million - $5.65 Million	-27,092 Reduced 8.5%	291,727 $56.5 Million
Q2 2019 Jul 09, 2019	SELL	$166.7 - $195.41 $282,889 - $331,610	-1,697 Reduced 0.53%	318,819 $58.8 Million
Q1 2019 Apr 15, 2019	SELL	$180.87 - $203.88 $1.29 Million - $1.46 Million	-7,153 Reduced 2.18%	320,516 $60.9 Million
Q4 2018 Jan 10, 2019	SELL	$178.4 - $208.25 $10.7 Million - $12.5 Million	-59,801 Reduced 15.43%	327,669 $63.8 Million
Q3 2018 Oct 24, 2018	SELL	$185.29 - $208.89 $3.22 Million - $3.63 Million	-17,395 Reduced 4.3%	387,470 $80.3 Million
Q2 2018 Jul 17, 2018	SELL	$166.05 - $186.51 $11.9 Million - $13.4 Million	-71,736 Reduced 15.05%	404,865 $74.7 Million
Q1 2018 Apr 27, 2018	SELL	$169.43 - $198.0 $5.38 Million - $6.29 Million	-31,752 Reduced 6.25%	476,601 $81.3 Million
Q4 2017 Feb 08, 2018	SELL	$168.79 - $188.59 $164,907 - $184,252	-977 Reduced 0.19%	508,353 $88.4 Million
Q3 2017 Nov 06, 2017	BUY	$167.29 - $191.0 $85.2 Million - $97.3 Million	509,330	509,330 $95 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Systems Of Alabama, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Systems Of Alabama with notifications on news.

Account

Retirement Systems Of Alabama Amgen Inc Transaction History